Rigel Pharmaceuticals | 売上総利益





売上総利益 変化する 日付
Agenus USD 23.93M 2.79M 2025-03
Amgen USD 6.48B 307M 2025-09
Anika Therapeutics USD 14.68M 9.46M 2025-03
Arrowhead Research USD 256.47M 228.7M 2025-09
AstraZeneca USD 12.39B 5M 2025-12
BioMarin Pharmaceutical USD 631.2M 39.27M 2025-09
Bristol-Myers Squibb USD 8.79B 110M 2025-09
Celldex Therapeutics USD 730K 35K 2025-06
Daiichi Sankyo JPY 439.83B 95.05B 2025-12
Eli Lilly USD 14.59B 1.48B 2025-09
Halozyme Therapeutics USD 281.77M 2.41M 2025-09
Heron Therapeutics USD 23.35M 1.6M 2024-09
Intrexon USD -297K 167K 2024-06
Ionis Pharmaceuticals USD 155M 293M 2025-09
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
Ligand Pharmaceuticals USD 155.28M 82.42M 2025-09
MacroGenics USD 61.25M 88.71M 2025-09
Neurocrine Biosciences USD 780.9M 104.7M 2025-09
Pfizer USD 3.54B 7.61B 2025-09
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Rigel Pharmaceuticals USD 28.49M 7.01M 2024-06
Sangamo BioSciences -2.39M 1.09M 2024-06
Ultragenyx Pharmaceutical USD 131.94M 11.55M 2025-09
Veracyte USD 91.28M 1.51M 2025-09


Rigel Pharmaceuticals 売上総利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Feb 2026.